Monkeypox: Pathogenesis, Prevention, Threats, Challenges and Immune Response Against It

A rare zoonotic disease, monkeypox is brought on by the Monkeypox virus, which is a member of the Orthopoxvirus genus, Chordopoxvirinae subfamily, and Poxviridae family. Smallpox-like symptoms are brought on by the monkeypox disease, which is closely linked to the variola virus (smallpox virus). In the past, it has been demonstrated that smallpox vaccination with the vaccinia virus (another orthopoxvirus) is 85% protective against monkeypox. The two most likely forms of monkeypox transmission are animal-human transmission and human-human transmission. Transmission between people has been connected to respiratory droplets, coming into contact with bodily fluids, contaminated patient things or surroundings, and skin lesions on infected people. Numerous strategies or tactics have been developed by monkeypox to subvert or exacerbate the host’s immune reaction to infection. A crucial element of innate immunity, natural killer [NK] cells employ cytokines to kill virus-infected cells and interfere with the operation of other cell types like T cells and dendritic cells. Studies have shown that the smallpox vaccine provides cross-protection against other Orthopoxvirus species, including monkeypox. This study was out to provide a thorough overview of the pathogenesis, prevention, risks, immune response problems, and analysis of possible concerns associated with the monkeypox virus.